Rapid reduction of nasal melanoma by nivolumab.
Department of Dermatology.
Kohei
K
Nojima
Department of Dermatology.
Takeshi
T
Namiki
Department of Dermatology.
Keiko
K
Inui
Department of Dermatology.
Takaaki
T
Hanafusa
Department of Pathology.
Keiko
K
Miura
Department of Head and Neck Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510 Japan.
Takahiro
T
Asakage
Department of Dermatology.
Hiroo
H
Yokozeki
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000556:secondary / Q000628:therapy*; D009296:Nasal Cavity; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D000077594:Nivolumab; D009669:Nose Neoplasms / Q000473:pathology / Q000628:therapy*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab